# Jilin Cancer Hospital

Source: https://onco.cc/institutions/jilin-cancer-hospital/  
OnCo record `jilin-cancer-hospital` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Jilin Cancer Hospital in Changchun is the centre that led China's small cell lung cancer immunotherapy trials, including ASTRUM-005 and CAPSTONE-1.

## Summary

Provincial cancer centre whose thoracic oncology department under Cheng Ying has been principal investigator for serplulimab (ASTRUM-005), adebrelimab (CAPSTONE-1), benmelstobart plus anlotinib and other extensive-stage SCLC trials, making a north-eastern provincial hospital one of the most cited sites in the disease.

## Fields

- Kind: Institution
- Last checked: 2026-09-10
- Also known as: 吉林省肿瘤医院
- Tags: china
- City: Changchun, CN
- Type: cancer-center
- Website: https://www.jlszlyy.com/

## Sources

- Official website: https://www.jlszlyy.com/

## Connected records

- cancers: [Small-cell lung cancer](https://onco.cc/cancers/sclc/)
- drugs: [Adebrelimab](https://onco.cc/drugs/adebrelimab/), [Serplulimab](https://onco.cc/drugs/serplulimab/)
- trials: [ASTRUM-005](https://onco.cc/trials/astrum-005/), [CAPSTONE-1](https://onco.cc/trials/capstone-1/)
- people: [Ying Cheng](https://onco.cc/people/cheng-ying/)

---
JSON: https://onco.cc/api/v1/entities/jilin-cancer-hospital.json